Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-44
Closed -$4K 873
2022
Q4
$4K Sell
44
-108
-71% -$9.19K ﹤0.01% 716
2022
Q3
$12K Buy
152
+36
+31% +$3.05K ﹤0.01% 604
2022
Q2
$10K Buy
+116
New +$9.56K ﹤0.01% 592
2020
Q1
Sell
-47
Closed -$3K 195
2019
Q4
$3K Buy
+47
New +$3.2K ﹤0.01% 213

Other funds holding DOX

Crewe Advisors's DOX Position: Q1 2023 in Review

Crewe Advisors sold out of Amdocs (DOX) in Q1 2023, closing a stake of 44 shares — an estimated $4K sold.

Crewe Advisors first reported a position in DOX in Q4 2019 and held it in 4 quarters. The position peaked at $12K in Q3 2022. 455 funds tracked by Wall St. Rank hold DOX as of Q1 2023.

  • Crewe Advisors reported no remaining Amdocs position as of Q1 2023 after selling out during the quarter.
  • Crewe Advisors sold 44 Amdocs shares in Q1 2023, an estimated $4K.
  • Crewe Advisors first reported a position in Amdocs in Q4 2019 and held it in 4 quarters.
  • Crewe Advisors's Amdocs position peaked at $12K in Q3 2022.
  • 455 funds tracked by Wall St. Rank held Amdocs as of Q1 2023.

Based on Crewe Advisors's 13F filing for Q1 2023, filed 12 May 2023.